{"id":418636,"date":"2025-09-12T14:19:11","date_gmt":"2025-09-12T14:19:11","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/418636\/"},"modified":"2025-09-12T14:19:11","modified_gmt":"2025-09-12T14:19:11","slug":"merck-nixes-planned-london-rd-center","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/418636\/","title":{"rendered":"Merck Nixes Planned London R&#038;D Center"},"content":{"rendered":"<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\">Merck will not build its planned research operations in London, citing the UK&#8217;s challenging business environment, and would relocate the research activity to existing sites primarily in the United States.<\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\">The US pharmaceutical company no longer plans to occupy the Belgrove House site at King&#8217;s Cross, which was due to open in 2027.\u00a0<\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\">The move will impact about 125 staff members, Reuters reported.\u00a0The US plant is slated to be operational by 2028, with experimental drug production starting by 2030.<\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\">In March, <a class=\"ContentText-BodyTextChunk ContentText-BodyTextChunk_link\" target=\"_self\" href=\"https:\/\/www.powderbulksolids.com\/pharmaceuticals-medical-products\/merck-opens-1b-vaccine-manufacturing-facility\" rel=\"noopener\">Merck also opened a $1 billion vaccine facility<\/a> in Durham, NC.\u00a0The company&#8217;s animal health unit will also invest $895 million to expand its Kansas manufacturing and R&amp;D site, part of a broader $9 billion U.S. investment through 2028.<\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\">This isn&#8217;t the only pharma giant who has brought manufacturing back to or investing more into the US. <a class=\"ContentText-BodyTextChunk ContentText-BodyTextChunk_link\" target=\"_self\" href=\"https:\/\/www.powderbulksolids.com\/pharmaceuticals-medical-products\/amgen-investing-600m-in-new-r-d-center\" rel=\"noopener\">Amgen announced last week that it is putting $600M into a new R&amp;D center<\/a> in Thousand Oaks, CA, where it is headquartered.\u00a0<\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\">As well, Johnson &amp; Johnson, AbbVie, AstraZenica, Lilly, and Novartis have all poured millions into US manufacturing this year.<\/p>\n","protected":false},"excerpt":{"rendered":"Merck will not build its planned research operations in London, citing the UK&#8217;s challenging business environment, and would&hellip;\n","protected":false},"author":2,"featured_media":418637,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7757],"tags":[748,393,4884,257,16,15],"class_list":{"0":"post-418636","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-london","8":"tag-britain","9":"tag-england","10":"tag-great-britain","11":"tag-london","12":"tag-uk","13":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115191766340957784","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/418636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=418636"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/418636\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/418637"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=418636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=418636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=418636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}